 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004526	ribonuclease P activity	1	3.841069e-4	1.000000e+0	1.000000e+0	2.603442e+3	3.841069e-4	1	3.841069e-4	1.000000e+0	1	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	RPP21
GO Molecular Function	GO:0004549	tRNA-specific ribonuclease activity	2	7.058971e-4	1.000000e+0	1.000000e+0	1.416637e+3	7.058971e-4	1	7.058971e-4	1.000000e+0	2	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	RPP21
GO Molecular Function	GO:0042605	peptide antigen binding	3	9.127733e-4	1.000000e+0	1.000000e+0	1.095562e+3	9.127733e-4	1	9.127733e-4	1.000000e+0	3	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	HLA-E
GO Molecular Function	GO:0016891	endoribonuclease activity, producing 5'-phosphomonoesters	4	1.270370e-3	1.000000e+0	1.000000e+0	7.871721e+2	1.270370e-3	1	1.270370e-3	1.000000e+0	4	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	RPP21
GO Molecular Function	GO:0016893	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	5	1.714712e-3	1.000000e+0	1.000000e+0	5.831883e+2	1.714712e-3	1	1.714712e-3	1.000000e+0	5	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	RPP21
GO Molecular Function	GO:0004521	endoribonuclease activity	6	1.998571e-3	1.000000e+0	1.000000e+0	5.003575e+2	1.998571e-3	1	1.998571e-3	1.000000e+0	6	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	RPP21
GO Molecular Function	GO:0003823	antigen binding	7	2.304686e-3	1.000000e+0	1.000000e+0	4.338986e+2	2.304686e-3	1	2.304686e-3	1.000000e+0	7	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	HLA-E
GO Molecular Function	GO:0004540	ribonuclease activity	8	4.175349e-3	1.000000e+0	1.000000e+0	2.395010e+2	4.175349e-3	1	4.175349e-3	1.000000e+0	8	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	RPP21
GO Molecular Function	GO:0004519	endonuclease activity	9	6.740356e-3	1.000000e+0	1.000000e+0	1.483601e+2	6.740356e-3	1	6.740356e-3	1.000000e+0	9	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	RPP21
GO Molecular Function	GO:0004518	nuclease activity	10	1.159861e-2	1.000000e+0	1.000000e+0	8.621724e+1	1.159861e-2	1	1.159861e-2	1.000000e+0	12	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	RPP21
GO Molecular Function	GO:0042277	peptide binding	11	1.583040e-2	1.000000e+0	1.000000e+0	6.316962e+1	1.583040e-2	1	1.583040e-2	1.000000e+0	10	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	HLA-E
GO Molecular Function	GO:0033218	amide binding	12	1.625719e-2	1.000000e+0	1.000000e+0	6.151126e+1	1.625719e-2	1	1.625719e-2	1.000000e+0	11	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	HLA-E
GO Molecular Function	GO:0016788	hydrolase activity, acting on ester bonds	13	6.759571e-2	1.000000e+0	1.000000e+0	1.479384e+1	6.759571e-2	1	6.759571e-2	1.000000e+0	13	8.226776e-2	1.000000e+0	1.000000e+0	1.190040e+1	8.403082e-2	1	758	5.000000e-1	1.319261e-3	unnamed	RPP21
GO Molecular Function	GO:0005102	receptor binding	14	1.214505e-1	1.000000e+0	1.000000e+0	8.233804e+0	1.214505e-1	1	1.214505e-1	1.000000e+0	14	1.292303e-1	1.000000e+0	1.000000e+0	7.479685e+0	1.336955e-1	1	1206	5.000000e-1	8.291874e-4	unnamed	HLA-E
GO Molecular Function	GO:0016787	hydrolase activity	15	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	15	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	RPP21
GO Molecular Function	GO:0003824	catalytic activity	16	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	16	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	RPP21
GO Molecular Function	GO:0005515	protein binding	17	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	17	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	HLA-E
GO Molecular Function	GO:0005488	binding	18	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	18	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	HLA-E
GO Biological Process	GO:0001916	positive regulation of T cell mediated cytotoxicity	1	1.697817e-3	1.000000e+0	1.000000e+0	5.889918e+2	1.697817e-3	1	1.697817e-3	1.000000e+0	1	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	HLA-E
GO Biological Process	GO:0001914	regulation of T cell mediated cytotoxicity	2	2.345367e-3	1.000000e+0	1.000000e+0	4.263724e+2	2.345367e-3	1	2.345367e-3	1.000000e+0	2	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	HLA-E
GO Biological Process	GO:0002711	positive regulation of T cell mediated immunity	3	2.653149e-3	1.000000e+0	1.000000e+0	3.769106e+2	2.653149e-3	1	2.653149e-3	1.000000e+0	3	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	HLA-E
GO Biological Process	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	4	3.500773e-3	1.000000e+0	1.000000e+0	2.856512e+2	3.500773e-3	1	3.500773e-3	1.000000e+0	3	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	HLA-E
GO Biological Process	GO:0031343	positive regulation of cell killing	5	3.737918e-3	1.000000e+0	1.000000e+0	2.675286e+2	3.737918e-3	1	3.737918e-3	1.000000e+0	5	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	HLA-E
GO Biological Process	GO:0002709	regulation of T cell mediated immunity	6	3.838101e-3	1.000000e+0	1.000000e+0	2.605455e+2	3.838101e-3	1	3.838101e-3	1.000000e+0	8	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	HLA-E
GO Biological Process	GO:0001910	regulation of leukocyte mediated cytotoxicity	7	4.195376e-3	1.000000e+0	1.000000e+0	2.383577e+2	4.195376e-3	1	4.195376e-3	1.000000e+0	6	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	HLA-E
GO Biological Process	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	8	4.205891e-3	1.000000e+0	1.000000e+0	2.377618e+2	4.205891e-3	1	4.205891e-3	1.000000e+0	9	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	HLA-E
GO Biological Process	GO:0031341	regulation of cell killing	9	4.432521e-3	1.000000e+0	1.000000e+0	2.256053e+2	4.432521e-3	1	4.432521e-3	1.000000e+0	7	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	HLA-E
GO Biological Process	GO:0002708	positive regulation of lymphocyte mediated immunity	10	4.543691e-3	1.000000e+0	1.000000e+0	2.200854e+2	4.543691e-3	1	4.543691e-3	1.000000e+0	10	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	HLA-E
GO Biological Process	GO:0002821	positive regulation of adaptive immune response	11	4.680873e-3	1.000000e+0	1.000000e+0	2.136353e+2	4.680873e-3	1	4.680873e-3	1.000000e+0	11	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	HLA-E
GO Biological Process	GO:0002705	positive regulation of leukocyte mediated immunity	12	4.730461e-3	1.000000e+0	1.000000e+0	2.113959e+2	4.730461e-3	1	4.730461e-3	1.000000e+0	11	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	HLA-E
GO Biological Process	GO:0008033	tRNA processing	13	4.925333e-3	1.000000e+0	1.000000e+0	2.030320e+2	4.925333e-3	1	4.925333e-3	1.000000e+0	13	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	RPP21
GO Biological Process	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I	14	5.169846e-3	1.000000e+0	1.000000e+0	1.934294e+2	5.169846e-3	1	5.169846e-3	1.000000e+0	15	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	HLA-E
GO Biological Process	GO:0002706	regulation of lymphocyte mediated immunity	15	7.210328e-3	1.000000e+0	1.000000e+0	1.386900e+2	7.210328e-3	1	7.210328e-3	1.000000e+0	14	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	HLA-E
GO Biological Process	GO:0006399	tRNA metabolic process	16	8.440032e-3	1.000000e+0	1.000000e+0	1.184830e+2	8.440032e-3	1	8.440032e-3	1.000000e+0	20	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	RPP21
GO Biological Process	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	17	8.696557e-3	1.000000e+0	1.000000e+0	1.149880e+2	8.696557e-3	1	8.696557e-3	1.000000e+0	16	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	HLA-E
GO Biological Process	GO:0002703	regulation of leukocyte mediated immunity	18	8.907724e-3	1.000000e+0	1.000000e+0	1.122621e+2	8.907724e-3	1	8.907724e-3	1.000000e+0	19	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	HLA-E
GO Biological Process	GO:0002819	regulation of adaptive immune response	19	9.957988e-3	1.000000e+0	1.000000e+0	1.004219e+2	9.957988e-3	1	9.957988e-3	1.000000e+0	17	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	HLA-E
GO Biological Process	GO:0002699	positive regulation of immune effector process	20	1.132648e-2	1.000000e+0	1.000000e+0	8.828870e+1	1.132648e-2	1	1.132648e-2	1.000000e+0	18	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	HLA-E
GO Biological Process	GO:0048002	antigen processing and presentation of peptide antigen	21	1.141742e-2	1.000000e+0	1.000000e+0	8.758544e+1	1.141742e-2	1	1.141742e-2	1.000000e+0	21	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	HLA-E
GO Biological Process	GO:0019882	antigen processing and presentation	22	1.236721e-2	1.000000e+0	1.000000e+0	8.085898e+1	1.236721e-2	1	1.236721e-2	1.000000e+0	22	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	HLA-E
GO Biological Process	GO:0034470	ncRNA processing	23	1.300368e-2	1.000000e+0	1.000000e+0	7.690130e+1	1.300368e-2	1	1.300368e-2	1.000000e+0	23	2.456936e-2	1.000000e+0	1.000000e+0	4.045067e+1	2.472147e-2	1	223	5.000000e-1	4.484305e-3	unnamed	RPP21
GO Biological Process	GO:0034660	ncRNA metabolic process	24	1.918569e-2	1.000000e+0	1.000000e+0	5.212218e+1	1.918569e-2	1	1.918569e-2	1.000000e+0	25	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	RPP21
GO Biological Process	GO:0002697	regulation of immune effector process	25	1.998967e-2	1.000000e+0	1.000000e+0	5.002584e+1	1.998967e-2	1	1.998967e-2	1.000000e+0	24	2.763270e-2	1.000000e+0	1.000000e+0	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	HLA-E
GO Biological Process	GO:0050778	positive regulation of immune response	26	3.752675e-2	1.000000e+0	1.000000e+0	2.664765e+1	3.752675e-2	1	3.752675e-2	1.000000e+0	27	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	HLA-E
GO Biological Process	GO:0042493	response to drug	27	4.125969e-2	1.000000e+0	1.000000e+0	2.423673e+1	4.125969e-2	1	4.125969e-2	1.000000e+0	26	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	RPP21
GO Biological Process	GO:0006396	RNA processing	28	4.781684e-2	1.000000e+0	1.000000e+0	2.091314e+1	4.781684e-2	1	4.781684e-2	1.000000e+0	29	7.257778e-2	1.000000e+0	1.000000e+0	1.352399e+1	7.394269e-2	1	667	5.000000e-1	1.499250e-3	unnamed	RPP21
GO Biological Process	GO:0002684	positive regulation of immune system process	29	5.813980e-2	1.000000e+0	1.000000e+0	1.719992e+1	5.813980e-2	1	5.813980e-2	1.000000e+0	28	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	HLA-E
GO Biological Process	GO:0050776	regulation of immune response	30	6.220372e-2	1.000000e+0	1.000000e+0	1.607621e+1	6.220372e-2	1	6.220372e-2	1.000000e+0	30	7.588448e-2	1.000000e+0	1.000000e+0	1.292335e+1	7.737930e-2	1	698	5.000000e-1	1.432665e-3	unnamed	HLA-E
GO Biological Process	GO:0006955	immune response	31	8.762627e-2	1.000000e+0	1.000000e+0	1.141210e+1	8.762627e-2	1	8.762627e-2	1.000000e+0	32	1.192707e-1	1.000000e+0	1.000000e+0	8.126577e+0	1.230530e-1	1	1110	5.000000e-1	9.009009e-4	unnamed	HLA-E
GO Biological Process	GO:0002682	regulation of immune system process	32	1.008798e-1	1.000000e+0	1.000000e+0	9.912784e+0	1.008798e-1	1	1.008798e-1	1.000000e+0	31	1.146870e-1	1.000000e+0	1.000000e+0	8.462008e+0	1.181753e-1	1	1066	5.000000e-1	9.380863e-4	unnamed	HLA-E
GO Biological Process	GO:0048584	positive regulation of response to stimulus	33	1.367746e-1	1.000000e+0	1.000000e+0	7.311300e+0	1.367746e-1	1	1.367746e-1	1.000000e+0	33	1.352201e-1	1.000000e+0	1.000000e+0	7.136472e+0	1.401253e-1	1	1264	5.000000e-1	7.911392e-4	unnamed	HLA-E
GO Biological Process	GO:0002376	immune system process	34	1.536349e-1	1.000000e+0	1.000000e+0	6.508938e+0	1.536349e-1	1	1.536349e-1	1.000000e+0	35	1.884977e-1	1.000000e+0	1.000000e+0	5.042202e+0	1.983260e-1	1	1789	5.000000e-1	5.589715e-4	unnamed	HLA-E
GO Biological Process	GO:0016070	RNA metabolic process	35	2.686590e-1	1.000000e+0	1.000000e+0	3.722190e+0	2.686590e-1	1	2.686590e-1	1.000000e+0	37	3.211950e-1	1.000000e+0	1.000000e+0	2.839314e+0	3.521978e-1	1	3177	5.000000e-1	3.147624e-4	unnamed	RPP21
GO Biological Process	GO:0048583	regulation of response to stimulus	36	2.696284e-1	1.000000e+0	1.000000e+0	3.708809e+0	2.696284e-1	1	2.696284e-1	1.000000e+0	36	2.749464e-1	1.000000e+0	1.000000e+0	3.367115e+0	2.969902e-1	1	2679	5.000000e-1	3.732736e-4	unnamed	HLA-E
GO Biological Process	GO:0010467	gene expression	37	2.836887e-1	1.000000e+0	1.000000e+0	3.524990e+0	2.836887e-1	1	2.836887e-1	1.000000e+0	39	3.441967e-1	1.000000e+0	1.000000e+0	2.629117e+0	3.803559e-1	1	3431	5.000000e-1	2.914602e-4	unnamed	RPP21
GO Biological Process	GO:0042221	response to chemical stimulus	38	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	38	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	RPP21
GO Biological Process	GO:0090304	nucleic acid metabolic process	39	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	41	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	RPP21
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	40	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	42	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	RPP21
GO Biological Process	GO:0046483	heterocycle metabolic process	41	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	43	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	RPP21
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	42	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	44	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	RPP21
GO Biological Process	GO:0048518	positive regulation of biological process	43	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	40	3.689175e-1	1.000000e+0	1.000000e+0	2.432057e+0	4.111745e-1	1	3709	5.000000e-1	2.696145e-4	unnamed	HLA-E
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	44	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	45	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	RPP21
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	45	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	46	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	RPP21
GO Biological Process	GO:0006807	nitrogen compound metabolic process	46	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	47	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	RPP21
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	47	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	48	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	RPP21
GO Biological Process	GO:0043170	macromolecule metabolic process	48	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	49	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	RPP21
GO Biological Process	GO:0050896	response to stimulus	49	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	34	1.457136e-1	1.000000e+0	1.000000e+0	2.619573e+0	7.634832e-1	2	6887	1.000000e+0	2.904022e-4	unnamed	HLA-E,RPP21
GO Biological Process	GO:0044237	cellular metabolic process	50	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	50	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	RPP21
GO Biological Process	GO:0044238	primary metabolic process	51	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	51	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	RPP21
GO Biological Process	GO:0071704	organic substance metabolic process	52	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	52	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	RPP21
GO Biological Process	GO:0008152	metabolic process	53	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	53	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	RPP21
GO Biological Process	GO:0050789	regulation of biological process	54	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	54	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	HLA-E
GO Biological Process	GO:0065007	biological regulation	55	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	55	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	HLA-E
GO Biological Process	GO:0009987	cellular process	56	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	56	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	RPP21
GO Cellular Component	GO:0042612	MHC class I protein complex	1	5.606058e-4	7.091663e-1	7.091663e-1	1.783785e+3	5.606058e-4	1	5.606058e-4	1.000000e+0	1	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	HLA-E
GO Cellular Component	GO:0042611	MHC protein complex	2	8.278895e-4	1.000000e+0	5.236401e-1	1.207891e+3	8.278895e-4	1	8.278895e-4	1.000000e+0	2	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	HLA-E
GO Cellular Component	GO:0005730	nucleolus	3	5.338243e-2	1.000000e+0	1.000000e+0	1.873275e+1	5.338243e-2	1	5.338243e-2	1.000000e+0	3	7.118934e-2	1.000000e+0	1.000000e+0	1.379281e+1	7.250152e-2	1	654	5.000000e-1	1.529052e-3	unnamed	RPP21
GO Cellular Component	GO:0031981	nuclear lumen	4	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	4	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	RPP21
GO Cellular Component	GO:0044428	nuclear part	5	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	6	2.552742e-1	1.000000e+0	1.000000e+0	3.649070e+0	2.740425e-1	1	2472	5.000000e-1	4.045307e-4	unnamed	RPP21
GO Cellular Component	GO:0070013	intracellular organelle lumen	6	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	7	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	RPP21
GO Cellular Component	GO:0043233	organelle lumen	7	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	8	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	RPP21
GO Cellular Component	GO:0031974	membrane-enclosed lumen	8	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	9	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	RPP21
GO Cellular Component	GO:0044459	plasma membrane part	9	2.354746e-1	1.000000e+0	1.000000e+0	4.246743e+0	2.354746e-1	1	2.354746e-1	1.000000e+0	4	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	HLA-E
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	10	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	10	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	RPP21
GO Cellular Component	GO:0043234	protein complex	11	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	11	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	HLA-E
GO Cellular Component	GO:0032991	macromolecular complex	12	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	12	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	HLA-E
GO Cellular Component	GO:0005886	plasma membrane	13	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	13	4.264607e-1	1.000000e+0	1.000000e+0	2.060416e+0	4.853390e-1	1	4378	5.000000e-1	2.284148e-4	unnamed	HLA-E
GO Cellular Component	GO:0071944	cell periphery	14	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	14	4.347424e-1	1.000000e+0	1.000000e+0	2.014854e+0	4.963140e-1	1	4477	5.000000e-1	2.233639e-4	unnamed	HLA-E
GO Cellular Component	GO:0016021	integral to membrane	15	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	15	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	HLA-E
GO Cellular Component	GO:0031224	intrinsic to membrane	16	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	16	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	HLA-E
GO Cellular Component	GO:0044446	intracellular organelle part	17	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	19	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	RPP21
GO Cellular Component	GO:0005634	nucleus	18	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	17	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	RPP21
GO Cellular Component	GO:0044422	organelle part	19	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	20	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	RPP21
GO Cellular Component	GO:0044425	membrane part	20	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	18	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	HLA-E
GO Cellular Component	GO:0016020	membrane	21	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	23	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	HLA-E
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	22	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	24	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	RPP21
GO Cellular Component	GO:0043227	membrane-bounded organelle	23	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	25	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	RPP21
GO Cellular Component	GO:0043229	intracellular organelle	24	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	26	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	RPP21
GO Cellular Component	GO:0043226	organelle	25	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	27	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	RPP21
GO Cellular Component	GO:0044424	intracellular part	26	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	28	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	RPP21
GO Cellular Component	GO:0005622	intracellular	27	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	29	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	RPP21
GO Cellular Component	GO:0044464	cell part	28	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	21	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	HLA-E,RPP21
GO Cellular Component	GO:0005623	cell	29	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	22	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	HLA-E,RPP21
Disease Ontology	DOID:1852	intrahepatic cholestasis	1	1.795804e-3	1.000000e+0	1.000000e+0	5.568536e+2	1.795804e-3	1	1.795804e-3	1.000000e+0	1	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	HLA-E
Disease Ontology	DOID:10923	sickle cell anemia	2	2.656963e-3	1.000000e+0	1.000000e+0	3.763696e+2	2.656963e-3	1	2.656963e-3	1.000000e+0	2	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	HLA-E
Disease Ontology	DOID:13378	mucocutaneous lymph node syndrome	3	4.576662e-3	1.000000e+0	1.000000e+0	2.184999e+2	4.576662e-3	1	4.576662e-3	1.000000e+0	5	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	HLA-E
Disease Ontology	DOID:437	myasthenia gravis	4	4.934327e-3	1.000000e+0	1.000000e+0	2.026619e+2	4.934327e-3	1	4.934327e-3	1.000000e+0	3	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	HLA-E
Disease Ontology	DOID:439	neuromuscular junction disease	5	5.061766e-3	1.000000e+0	1.000000e+0	1.975595e+2	5.061766e-3	1	5.061766e-3	1.000000e+0	4	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	HLA-E
Disease Ontology	DOID:1602	lymphadenitis	6	5.295759e-3	1.000000e+0	1.000000e+0	1.888303e+2	5.295759e-3	1	5.295759e-3	1.000000e+0	7	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	HLA-E
Disease Ontology	DOID:722	spontaneous abortion	7	5.907872e-3	1.000000e+0	1.000000e+0	1.692657e+2	5.907872e-3	1	5.907872e-3	1.000000e+0	9	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	HLA-E
Disease Ontology	DOID:13580	cholestasis	8	6.020580e-3	1.000000e+0	1.000000e+0	1.660969e+2	6.020580e-3	1	6.020580e-3	1.000000e+0	8	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	HLA-E
Disease Ontology	DOID:13241	Behcet's disease	9	6.146019e-3	1.000000e+0	1.000000e+0	1.627069e+2	6.146019e-3	1	6.146019e-3	1.000000e+0	12	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	HLA-E
Disease Ontology	DOID:438	autoimmune disease of the nervous system	10	6.195401e-3	1.000000e+0	1.000000e+0	1.614100e+2	6.195401e-3	1	6.195401e-3	1.000000e+0	5	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	HLA-E
Disease Ontology	DOID:6590	spondylitis	11	6.471028e-3	1.000000e+0	1.000000e+0	1.545349e+2	6.471028e-3	1	6.471028e-3	1.000000e+0	10	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	HLA-E
Disease Ontology	DOID:7147	ankylosing spondylitis	11	6.471028e-3	1.000000e+0	1.000000e+0	1.545349e+2	6.471028e-3	1	6.471028e-3	1.000000e+0	10	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	HLA-E
Disease Ontology	DOID:9810	polyarteritis nodosa	13	6.507454e-3	1.000000e+0	1.000000e+0	1.536699e+2	6.507454e-3	1	6.507454e-3	1.000000e+0	15	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	HLA-E
Disease Ontology	DOID:9219	pregnancy complication	14	6.843688e-3	1.000000e+0	1.000000e+0	1.461200e+2	6.843688e-3	1	6.843688e-3	1.000000e+0	12	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	HLA-E
Disease Ontology	DOID:1123	spondyloarthropathy	15	7.445347e-3	1.000000e+0	1.000000e+0	1.343121e+2	7.445347e-3	1	7.445347e-3	1.000000e+0	12	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	HLA-E
Disease Ontology	DOID:5366	pregnancy disease	16	7.627223e-3	1.000000e+0	1.000000e+0	1.311093e+2	7.627223e-3	1	7.627223e-3	1.000000e+0	16	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	HLA-E
Disease Ontology	DOID:11259	Cytomegalovirus infectious disease	17	8.345451e-3	1.000000e+0	1.000000e+0	1.198258e+2	8.345451e-3	1	8.345451e-3	1.000000e+0	18	1.347939e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	HLA-E
Disease Ontology	DOID:381	arthropathy	18	9.618936e-3	1.000000e+0	1.000000e+0	1.039616e+2	9.618936e-3	1	9.618936e-3	1.000000e+0	17	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	HLA-E
Disease Ontology	DOID:865	vasculitis	19	1.141538e-2	1.000000e+0	1.000000e+0	8.760113e+1	1.141538e-2	1	1.141538e-2	1.000000e+0	19	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	HLA-E
Disease Ontology	DOID:9540	vascular skin disease	20	1.340056e-2	1.000000e+0	1.000000e+0	7.462374e+1	1.340056e-2	1	1.340056e-2	1.000000e+0	20	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	HLA-E
Disease Ontology	DOID:8893	psoriasis	21	1.730046e-2	1.000000e+0	1.000000e+0	5.780195e+1	1.730046e-2	1	1.730046e-2	1.000000e+0	22	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	HLA-E
Disease Ontology	DOID:341	peripheral vascular disease	22	1.937384e-2	1.000000e+0	1.000000e+0	5.161599e+1	1.937384e-2	1	1.937384e-2	1.000000e+0	25	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	HLA-E
Disease Ontology	DOID:4138	bile duct disease	23	1.956557e-2	1.000000e+0	1.000000e+0	5.111019e+1	1.956557e-2	1	1.956557e-2	1.000000e+0	23	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	HLA-E
Disease Ontology	DOID:2355	anemia	24	1.971202e-2	1.000000e+0	1.000000e+0	5.073048e+1	1.971202e-2	1	1.971202e-2	1.000000e+0	26	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HLA-E
Disease Ontology	DOID:1883	hepatitis C	25	1.976589e-2	1.000000e+0	1.000000e+0	5.059220e+1	1.976589e-2	1	1.976589e-2	1.000000e+0	26	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HLA-E
Disease Ontology	DOID:2939	Herpesviridae infectious disease	26	2.018168e-2	1.000000e+0	1.000000e+0	4.954988e+1	2.018168e-2	1	2.018168e-2	1.000000e+0	29	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	HLA-E
Disease Ontology	DOID:1886	Flaviviridae infectious disease	27	2.129232e-2	1.000000e+0	1.000000e+0	4.696530e+1	2.129232e-2	1	2.129232e-2	1.000000e+0	30	2.763270e-2	1.000000e+0	1.000000e+0	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	HLA-E
Disease Ontology	DOID:9261	nasopharynx carcinoma	28	2.238691e-2	1.000000e+0	1.000000e+0	4.466897e+1	2.238691e-2	1	2.238691e-2	1.000000e+0	21	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
Disease Ontology	DOID:5223	infertility	29	2.336707e-2	1.000000e+0	1.000000e+0	4.279527e+1	2.336707e-2	1	2.336707e-2	1.000000e+0	24	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	HLA-E
Disease Ontology	DOID:9741	biliary tract disease	30	2.393130e-2	1.000000e+0	1.000000e+0	4.178628e+1	2.393130e-2	1	2.393130e-2	1.000000e+0	28	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	HLA-E
Disease Ontology	DOID:0050502	(+)ssRNA virus infectious disease	31	2.473880e-2	1.000000e+0	1.000000e+0	4.042233e+1	2.473880e-2	1	2.473880e-2	1.000000e+0	31	3.221869e-2	1.000000e+0	1.000000e+0	3.078669e+1	3.248157e-2	1	293	5.000000e-1	3.412969e-3	unnamed	HLA-E
Disease Ontology	DOID:3068	glioblastoma	32	3.687427e-2	1.000000e+0	1.000000e+0	2.711918e+1	3.687427e-2	1	3.687427e-2	1.000000e+0	32	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	HLA-E
Disease Ontology	DOID:0050498	dsDNA virus infectious disease	33	3.739700e-2	1.000000e+0	1.000000e+0	2.674011e+1	3.739700e-2	1	3.739700e-2	1.000000e+0	39	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	HLA-E
Disease Ontology	DOID:2237	hepatitis	34	3.759959e-2	1.000000e+0	1.000000e+0	2.659603e+1	3.759959e-2	1	3.759959e-2	1.000000e+0	38	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	HLA-E
Disease Ontology	DOID:1301	RNA virus infectious disease	35	4.155492e-2	1.000000e+0	1.000000e+0	2.406454e+1	4.155492e-2	1	4.155492e-2	1.000000e+0	42	5.304516e-2	1.000000e+0	1.000000e+0	1.859897e+1	5.376642e-2	1	485	5.000000e-1	2.061856e-3	unnamed	HLA-E
Disease Ontology	DOID:3069	astrocytoma	36	4.313016e-2	1.000000e+0	1.000000e+0	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	33	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	HLA-E
Disease Ontology	DOID:2126	primary brain tumor	37	4.334785e-2	1.000000e+0	1.000000e+0	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	34	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	HLA-E
Disease Ontology	DOID:911	malignant neoplasm of brain	38	4.364353e-2	1.000000e+0	1.000000e+0	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	35	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	HLA-E
Disease Ontology	DOID:368	neoplasm of cerebrum	39	4.511970e-2	1.000000e+0	1.000000e+0	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	36	4.298563e-2	1.000000e+0	1.000000e+0	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	HLA-E
Disease Ontology	DOID:1659	supratentorial neoplasm	40	4.529725e-2	1.000000e+0	1.000000e+0	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	37	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	HLA-E
Disease Ontology	DOID:937	DNA virus infectious disease	41	5.023839e-2	1.000000e+0	1.000000e+0	1.990510e+1	5.023839e-2	1	5.023839e-2	1.000000e+0	44	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	HLA-E
Disease Ontology	DOID:449	head neoplasm	42	5.090150e-2	1.000000e+0	1.000000e+0	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	40	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	HLA-E
Disease Ontology	DOID:37	skin disease	43	5.172018e-2	1.000000e+0	1.000000e+0	1.933481e+1	5.172018e-2	1	5.172018e-2	1.000000e+0	46	6.733902e-2	1.000000e+0	1.000000e+0	1.459628e+1	6.851061e-2	1	618	5.000000e-1	1.618123e-3	unnamed	HLA-E
Disease Ontology	DOID:229	female reproductive system disease	44	5.249388e-2	1.000000e+0	1.000000e+0	1.904984e+1	5.249388e-2	1	5.249388e-2	1.000000e+0	41	5.185810e-2	1.000000e+0	1.000000e+0	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	HLA-E
Disease Ontology	DOID:16	integumentary system disease	45	5.565040e-2	1.000000e+0	1.000000e+0	1.796932e+1	5.565040e-2	1	5.565040e-2	1.000000e+0	50	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	HLA-E
Disease Ontology	DOID:409	liver disease	46	5.695922e-2	1.000000e+0	1.000000e+0	1.755642e+1	5.695922e-2	1	5.695922e-2	1.000000e+0	47	6.862335e-2	1.000000e+0	1.000000e+0	1.431825e+1	6.984092e-2	1	630	5.000000e-1	1.587302e-3	unnamed	HLA-E
Disease Ontology	DOID:0050177	simple genetic disease	47	5.697693e-2	1.000000e+0	1.000000e+0	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	45	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	HLA-E
Disease Ontology	DOID:440	neuromuscular disease	48	6.093191e-2	1.000000e+0	1.000000e+0	1.641176e+1	6.093191e-2	1	6.093191e-2	1.000000e+0	43	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	HLA-E
Disease Ontology	DOID:630	genetic disease	49	6.499915e-2	1.000000e+0	1.000000e+0	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	49	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	HLA-E
Disease Ontology	DOID:3342	bone inflammation disease	50	6.811308e-2	1.000000e+0	1.000000e+0	1.468147e+1	6.811308e-2	1	6.811308e-2	1.000000e+0	51	7.268454e-2	1.000000e+0	1.000000e+0	1.350374e+1	7.405354e-2	1	668	5.000000e-1	1.497006e-3	unnamed	HLA-E
Disease Ontology	DOID:3118	hepatobiliary disease	51	6.824507e-2	1.000000e+0	1.000000e+0	1.465307e+1	6.824507e-2	1	6.824507e-2	1.000000e+0	55	8.109914e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	HLA-E
Disease Ontology	DOID:870	neuropathy	52	7.105799e-2	1.000000e+0	1.000000e+0	1.407301e+1	7.105799e-2	1	7.105799e-2	1.000000e+0	48	6.883732e-2	1.000000e+0	1.000000e+0	1.427294e+1	7.006264e-2	1	632	5.000000e-1	1.582278e-3	unnamed	HLA-E
Disease Ontology	DOID:417	autoimmune disease	53	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	63	8.820552e-2	1.000000e+0	1.000000e+0	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	HLA-E
Disease Ontology	DOID:1909	melanoma	54	8.029886e-2	1.000000e+0	1.000000e+0	1.245348e+1	8.029886e-2	1	8.029886e-2	1.000000e+0	52	7.599104e-2	1.000000e+0	1.000000e+0	1.290486e+1	7.749016e-2	1	699	5.000000e-1	1.430615e-3	unnamed	HLA-E
Disease Ontology	DOID:191	melanocytic neoplasm	55	8.062511e-2	1.000000e+0	1.000000e+0	1.240308e+1	8.062511e-2	1	8.062511e-2	1.000000e+0	53	7.631072e-2	1.000000e+0	1.000000e+0	1.284972e+1	7.782274e-2	1	702	5.000000e-1	1.424501e-3	unnamed	HLA-E
Disease Ontology	DOID:9256	colorectal cancer	56	8.071500e-2	1.000000e+0	1.000000e+0	1.238927e+1	8.071500e-2	1	8.071500e-2	1.000000e+0	54	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	HLA-E
Disease Ontology	DOID:934	viral infectious disease	57	8.111120e-2	1.000000e+0	1.000000e+0	1.232875e+1	8.111120e-2	1	8.111120e-2	1.000000e+0	66	9.991807e-2	1.000000e+0	1.000000e+0	9.751892e+0	1.025442e-1	1	925	5.000000e-1	1.081081e-3	unnamed	HLA-E
Disease Ontology	DOID:423	myopathy	58	8.319420e-2	1.000000e+0	1.000000e+0	1.202007e+1	8.319420e-2	1	8.319420e-2	1.000000e+0	56	8.152418e-2	1.000000e+0	1.000000e+0	1.201132e+1	8.325481e-2	1	751	5.000000e-1	1.331558e-3	unnamed	HLA-E
Disease Ontology	DOID:0080000	muscular disease	59	8.321398e-2	1.000000e+0	1.000000e+0	1.201721e+1	8.321398e-2	1	8.321398e-2	1.000000e+0	57	8.163042e-2	1.000000e+0	1.000000e+0	1.199535e+1	8.336567e-2	1	752	5.000000e-1	1.329787e-3	unnamed	HLA-E
Disease Ontology	DOID:0080001	bone disease	60	8.760496e-2	1.000000e+0	1.000000e+0	1.141488e+1	8.760496e-2	1	8.760496e-2	1.000000e+0	64	8.831138e-2	1.000000e+0	1.000000e+0	1.106810e+1	9.034976e-2	1	815	5.000000e-1	1.226994e-3	unnamed	HLA-E
Disease Ontology	DOID:1994	large Intestine carcinoma	61	8.851868e-2	1.000000e+0	1.000000e+0	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	61	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	HLA-E
Disease Ontology	DOID:15	reproductive system disease	62	8.872162e-2	1.000000e+0	1.000000e+0	1.127121e+1	8.872162e-2	1	8.872162e-2	1.000000e+0	58	8.290487e-2	1.000000e+0	1.000000e+0	1.180694e+1	8.469597e-2	1	764	5.000000e-1	1.308901e-3	unnamed	HLA-E
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	63	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	59	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	HLA-E
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	64	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	60	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	HLA-E
Disease Ontology	DOID:169	neuroendocrine tumor	65	9.840882e-2	1.000000e+0	1.000000e+0	1.016169e+1	9.840882e-2	1	9.840882e-2	1.000000e+0	65	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	HLA-E
Disease Ontology	DOID:3070	malignant glioma	66	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	62	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	HLA-E
Disease Ontology	DOID:75	lymphatic system disease	67	1.035697e-1	1.000000e+0	1.000000e+0	9.655335e+0	1.035697e-1	1	1.035697e-1	1.000000e+0	67	1.052741e-1	1.000000e+0	1.000000e+0	9.242316e+0	1.081980e-1	1	976	5.000000e-1	1.024590e-3	unnamed	HLA-E
Disease Ontology	DOID:170	endocrine gland cancer	68	1.163017e-1	1.000000e+0	1.000000e+0	8.598327e+0	1.163017e-1	1	1.163017e-1	1.000000e+0	68	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	HLA-E
Disease Ontology	DOID:3165	skin neoplasm	69	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	70	1.090453e-1	1.000000e+0	1.000000e+0	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	HLA-E
Disease Ontology	DOID:178	vascular disease	70	1.205522e-1	1.000000e+0	1.000000e+0	8.295164e+0	1.205522e-1	1	1.205522e-1	1.000000e+0	76	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	HLA-E
Disease Ontology	DOID:0050117	disease by infectious agent	71	1.209421e-1	1.000000e+0	1.000000e+0	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	80	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	HLA-E
Disease Ontology	DOID:2627	glioma	72	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	69	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	HLA-E
Disease Ontology	DOID:1319	brain neoplasm	73	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	71	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	HLA-E
Disease Ontology	DOID:3620	central nervous system neoplasm	74	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	72	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	HLA-E
Disease Ontology	DOID:171	neuroectodermal tumor	75	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	73	1.187505e-1	1.000000e+0	1.000000e+0	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	HLA-E
Disease Ontology	DOID:3095	germ cell and embryonal cancer	76	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	74	1.204148e-1	1.000000e+0	1.000000e+0	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	HLA-E
Disease Ontology	DOID:2994	germ cell cancer	77	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	75	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	HLA-E
Disease Ontology	DOID:177	soft tissue neoplasm	78	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	77	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	HLA-E
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	79	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	78	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	HLA-E
Disease Ontology	DOID:1115	sarcoma	80	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	79	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	HLA-E
Disease Ontology	DOID:77	gastrointestinal system disease	81	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	90	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	HLA-E
Disease Ontology	DOID:74	hematopoietic system disease	82	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	88	1.726418e-1	1.000000e+0	1.000000e+0	5.530656e+0	1.808104e-1	1	1631	5.000000e-1	6.131208e-4	unnamed	HLA-E
Disease Ontology	DOID:3094	neuroepithelial neoplasm	83	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	81	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	HLA-E
Disease Ontology	DOID:4241	malignant neoplasm of breast	84	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	84	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	HLA-E
Disease Ontology	DOID:3937	malignant neoplasm of thorax	85	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	85	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	HLA-E
Disease Ontology	DOID:3195	neural neoplasm	86	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	82	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	HLA-E
Disease Ontology	DOID:5093	thoracic cancer	87	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	86	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	HLA-E
Disease Ontology	DOID:3093	nervous system cancer	88	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	83	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	HLA-E
Disease Ontology	DOID:1612	mammary cancer	89	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	87	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	HLA-E
Disease Ontology	DOID:936	brain disease	90	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	89	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	HLA-E
Disease Ontology	DOID:193	reproductive system cancer	91	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	91	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	HLA-E
Disease Ontology	DOID:17	musculoskeletal system disease	92	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	93	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	HLA-E
Disease Ontology	DOID:155	glandular and epithelial neoplasm	93	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	92	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	HLA-E
Disease Ontology	DOID:331	central nervous system disease	94	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	94	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	HLA-E
Disease Ontology	DOID:1287	cardiovascular system disease	95	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	95	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	HLA-E
Disease Ontology	DOID:863	nervous system disease	96	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	96	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	HLA-E
Disease Ontology	DOID:2985	chronic rejection of renal transplant	97	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	97	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	HLA-E
Disease Ontology	DOID:2108	transplant-related disease	98	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	98	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	HLA-E
Disease Ontology	DOID:557	kidney disease	99	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	99	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	HLA-E
Disease Ontology	DOID:18	urinary system disease	100	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	100	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	HLA-E
Disease Ontology	DOID:2914	immune system disease	101	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	102	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	HLA-E
Disease Ontology	DOID:305	carcinoma	102	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	101	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	HLA-E
Disease Ontology	DOID:462	cancer by anatomical entity	103	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	103	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	HLA-E
Disease Ontology	DOID:162	cancer	104	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	104	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	HLA-E
Disease Ontology	DOID:7	disease of anatomical entity	105	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	105	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	HLA-E
Disease Ontology	DOID:4	disease	106	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	106	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_ICAM3	Neighborhood of ICAM3	1	2.160248e-3	9.224259e-1	9.224259e-1	4.629098e+2	2.160248e-3	1	2.160248e-3	1.000000e+0	6	4.318932e-3	1.000000e+0	3.073640e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_VAV1	Neighborhood of VAV1	2	2.197019e-3	9.381271e-1	4.690636e-1	4.551622e+2	2.197019e-3	1	2.197019e-3	1.000000e+0	3	3.987038e-3	1.000000e+0	5.674884e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_INPP5D	Neighborhood of INPP5D	3	2.229216e-3	9.518752e-1	3.172917e-1	4.485882e+2	2.229216e-3	1	2.229216e-3	1.000000e+0	7	4.761371e-3	1.000000e+0	2.904436e-1	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_HLA-C	Neighborhood of HLA-C	4	2.235602e-3	9.546021e-1	2.386505e-1	4.473067e+2	2.235602e-3	1	2.235602e-3	1.000000e+0	8	5.203711e-3	1.000000e+0	2.777481e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_CD48	Neighborhood of CD48	5	2.276809e-3	9.721974e-1	1.944395e-1	4.392112e+2	2.276809e-3	1	2.276809e-3	1.000000e+0	1	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_PTPN6	Neighborhood of PTPN6	6	2.312629e-3	9.874926e-1	1.645821e-1	4.324083e+2	2.312629e-3	1	2.312629e-3	1.000000e+0	8	5.203711e-3	1.000000e+0	2.777481e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_JAK1	Neighborhood of JAK1	7	3.131690e-3	1.000000e+0	1.910331e-1	3.193164e+2	3.131690e-3	1	3.131690e-3	1.000000e+0	1	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_CD53	Neighborhood of CD53	8	3.669266e-3	1.000000e+0	1.958471e-1	2.725341e+2	3.669266e-3	1	3.669266e-3	1.000000e+0	10	6.419641e-3	1.000000e+0	2.741187e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_CD97	Neighborhood of CD97	9	3.935695e-3	1.000000e+0	1.867269e-1	2.540847e+2	3.935695e-3	1	3.935695e-3	1.000000e+0	5	4.208307e-3	1.000000e+0	3.593894e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_RAP1B	Neighborhood of RAP1B	10	4.168007e-3	1.000000e+0	1.779739e-1	2.399228e+2	4.168007e-3	1	4.168007e-3	1.000000e+0	3	3.987038e-3	1.000000e+0	5.674884e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_STAT6	Neighborhood of STAT6	11	4.618799e-3	1.000000e+0	1.792934e-1	2.165065e+2	4.618799e-3	1	4.618799e-3	1.000000e+0	12	8.738896e-3	1.000000e+0	3.109590e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	HLA-E
MSigDB Cancer Neighborhood	GNF2_PTPRC	Neighborhood of PTPRC	12	4.965481e-3	1.000000e+0	1.766884e-1	2.013904e+2	4.965481e-3	1	4.965481e-3	1.000000e+0	11	7.524386e-3	1.000000e+0	2.920830e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	Graft-versus-host disease	1	1.747644e-3	1.000000e+0	1.000000e+0	5.721990e+2	1.747644e-3	1	1.747644e-3	1.000000e+0	2	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_ALLOGRAFT_REJECTION	Allograft rejection	2	2.043092e-3	1.000000e+0	1.000000e+0	4.894543e+2	2.043092e-3	1	2.043092e-3	1.000000e+0	1	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_AUTOIMMUNE_THYROID_DISEASE	Autoimmune thyroid disease	3	2.247344e-3	1.000000e+0	9.888314e-1	4.449697e+2	2.247344e-3	1	2.247344e-3	1.000000e+0	4	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	Antigen processing and presentation	4	2.364603e-3	1.000000e+0	7.803190e-1	4.229040e+2	2.364603e-3	1	2.364603e-3	1.000000e+0	6	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_TYPE_I_DIABETES_MELLITUS	Type I diabetes mellitus	5	2.885283e-3	1.000000e+0	7.617147e-1	3.465864e+2	2.885283e-3	1	2.885283e-3	1.000000e+0	3	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_VIRAL_MYOCARDITIS	Viral myocarditis	6	5.664993e-3	1.000000e+0	1.000000e+0	1.765227e+2	5.664993e-3	1	5.664993e-3	1.000000e+0	5	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	HLA-E
MSigDB Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	Natural killer cell mediated cytotoxicity	7	9.158783e-3	1.000000e+0	1.000000e+0	1.091848e+2	9.158783e-3	1	9.158783e-3	1.000000e+0	8	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	HLA-E
MSigDB Pathway	KEGG_ENDOCYTOSIS	Endocytosis	8	1.625319e-2	1.000000e+0	1.000000e+0	6.152638e+1	1.625319e-2	1	1.625319e-2	1.000000e+0	9	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	HLA-E
MSigDB Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	Cell adhesion molecules (CAMs)	9	1.672984e-2	1.000000e+0	1.000000e+0	5.977344e+1	1.672984e-2	1	1.672984e-2	1.000000e+0	7	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	HLA-E
MSigDB Perturbation	PASTURAL_RIZ1_TARGETS_UP	Genes up-regulated in K562 (chronic myelogenous leukemia, CML) cells engineered to stably express RIZ1 [GeneID=7799].	1	8.380309e-4	1.000000e+0	1.000000e+0	1.193273e+3	8.380309e-4	1	8.380309e-4	1.000000e+0	1	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	HLA-E
MSigDB Perturbation	KIM_LRRC3B_TARGETS	Immune response genes up-regulated in zenograft tumors formed by SNU-601 cells (gastric cancer) made to express LRRC3B [GeneID=116135].	2	1.239541e-3	1.000000e+0	1.000000e+0	8.067502e+2	1.239541e-3	1	1.239541e-3	1.000000e+0	2	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	HLA-E
MSigDB Perturbation	GNATENKO_PLATELET_SIGNATURE	Top 50 most up-regulated genes in human platelet cells.	3	2.089044e-3	1.000000e+0	1.000000e+0	4.786879e+2	2.089044e-3	1	2.089044e-3	1.000000e+0	5	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	HLA-E
MSigDB Perturbation	RADAEVA_RESPONSE_TO_IFNA1_UP	Genes up-regulated in primary hepatocytes and Hep3B (hepatocyte) cells in response to IFNA [GeneID=3439].	4	2.818272e-3	1.000000e+0	1.000000e+0	3.548274e+2	2.818272e-3	1	2.818272e-3	1.000000e+0	7	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	HLA-E
MSigDB Perturbation	KRASNOSELSKAYA_ILF3_TARGETS_UP	Up-regulated in GHOST(3)CXCR4 cells (osteosarcoma) upon ectopic expression of ILF3 [GeneID=3609].	5	2.984308e-3	1.000000e+0	1.000000e+0	3.350860e+2	2.984308e-3	1	2.984308e-3	1.000000e+0	4	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	HLA-E
MSigDB Perturbation	GAURNIER_PSMD4_TARGETS	Inflammatory cytokines, chemokines and their cognate receptors up-regulated in THP-1 cells (monocyte) after treatment with PSMD4 [GeneID=5710].	6	3.612894e-3	1.000000e+0	1.000000e+0	2.767864e+2	3.612894e-3	1	3.612894e-3	1.000000e+0	11	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	HLA-E
MSigDB Perturbation	SANA_RESPONSE_TO_IFNG_UP	Genes up-regulated in five primary endothelial cell types (lung, aortic, iliac, dermal, and colon) by IFNG [GeneID=3458].	7	3.884922e-3	1.000000e+0	1.000000e+0	2.574055e+2	3.884922e-3	1	3.884922e-3	1.000000e+0	13	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	HLA-E
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	Common up-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation.	8	4.194696e-3	1.000000e+0	1.000000e+0	2.383963e+2	4.194696e-3	1	4.194696e-3	1.000000e+0	15	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	HLA-E
MSigDB Perturbation	ZHU_CMV_8_HR_UP	Up-regulated at 8 h following infection of primary human foreskin fibroblasts with CMV	9	4.309896e-3	1.000000e+0	1.000000e+0	2.320242e+2	4.309896e-3	1	4.309896e-3	1.000000e+0	5	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	HLA-E
MSigDB Perturbation	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	Genes up-regulated in the A673 cells (Ewing sarcoma) after double knockdown of both FLI1 and DAX1 [GeneID=2313;190] by RNAi.	10	5.064179e-3	1.000000e+0	1.000000e+0	1.974654e+2	5.064179e-3	1	5.064179e-3	1.000000e+0	9	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	HLA-E
MSigDB Perturbation	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	ES/PNET (Ewing sarcoma; primitive neuroectodermal tumors) markers up-regulated in neuroblastoma cell lines expressing ESWR1-FLI1 [GeneID=2130;2313] fusion protein.	11	5.214584e-3	1.000000e+0	1.000000e+0	1.917699e+2	5.214584e-3	1	5.214584e-3	1.000000e+0	2	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	HLA-E
MSigDB Perturbation	DER_IFN_GAMMA_RESPONSE_UP	Genes up-regulated in HT1080 (fibrosarcoma) cells by treatment with interferon gamma for 6 h.	12	5.426189e-3	1.000000e+0	1.000000e+0	1.842914e+2	5.426189e-3	1	5.426189e-3	1.000000e+0	12	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	HLA-E
MSigDB Perturbation	DER_IFN_ALPHA_RESPONSE_UP	Genes up-regulated in HT1080 cells (fibrosarcoma) by treatment with interferon alpha for 6 h.	13	5.619523e-3	1.000000e+0	1.000000e+0	1.779510e+2	5.619523e-3	1	5.619523e-3	1.000000e+0	14	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	HLA-E
MSigDB Perturbation	WIELAND_UP_BY_HBV_INFECTION	Genes induced in the liver during hepatitis B (HBV) viral clearance in chimpanzees.	14	5.728455e-3	1.000000e+0	1.000000e+0	1.745671e+2	5.728455e-3	1	5.728455e-3	1.000000e+0	21	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	HLA-E
MSigDB Perturbation	LEE_EARLY_T_LYMPHOCYTE_DN	Genes down-regulated at early stages of progenitor T lymphocyte maturation compared to the late stages.	15	6.123022e-3	1.000000e+0	1.000000e+0	1.633181e+2	6.123022e-3	1	6.123022e-3	1.000000e+0	8	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	HLA-E
MSigDB Perturbation	ZHU_CMV_24_HR_UP	Up-regulated at 24 h following infection of primary human foreskin fibroblasts with CMV	16	7.020604e-3	1.000000e+0	1.000000e+0	1.424379e+2	7.020604e-3	1	7.020604e-3	1.000000e+0	20	1.050413e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	95	5.000000e-1	1.052632e-2	unnamed	HLA-E
MSigDB Perturbation	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	Genes up-regulated in HEK-293 cells (fibroblast) upon knockdown of both CTBP1 and SATB1 [GeneID=1487, 6304] by RNAi.	17	7.024133e-3	1.000000e+0	1.000000e+0	1.423663e+2	7.024133e-3	1	7.024133e-3	1.000000e+0	17	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	HLA-E
MSigDB Perturbation	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	Genes down-regulated in hepatocellular carcinoma (HCC) samples from patients with early recurrence (within 2 years after surgery) after resection.	18	7.082422e-3	1.000000e+0	1.000000e+0	1.411946e+2	7.082422e-3	1	7.082422e-3	1.000000e+0	10	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	RPP21
MSigDB Perturbation	DER_IFN_BETA_RESPONSE_UP	Genes up-regulated in HT1080 (fibrosarcoma) cells by treatment with interferon beta for 6 h.	19	7.820041e-3	1.000000e+0	1.000000e+0	1.278766e+2	7.820041e-3	1	7.820041e-3	1.000000e+0	22	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	HLA-E
MSigDB Perturbation	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	Genes up-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].	20	8.011843e-3	1.000000e+0	1.000000e+0	1.248152e+2	8.011843e-3	1	8.011843e-3	1.000000e+0	25	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	HLA-E
MSigDB Perturbation	GEORGANTAS_HSC_MARKERS	Genes up-regulated in HSC (hematopoietic stem cells) compared to HPC (hematopoietic progenitor cells).	21	8.755086e-3	1.000000e+0	1.000000e+0	1.142193e+2	8.755086e-3	1	8.755086e-3	1.000000e+0	16	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	HLA-E
MSigDB Perturbation	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	Up-regulated genes in lung tissue of smokers with chronic obstructive pulmonary disease (COPD) vs smokers without disease (GOLD-2 vs GOLD-0).	22	9.200267e-3	1.000000e+0	1.000000e+0	1.086925e+2	9.200267e-3	1	9.200267e-3	1.000000e+0	30	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	HLA-E
MSigDB Perturbation	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	Down-regulated genes in MDA-MB-435 cells (breast cancer) undergoing G2/M arrest after treatment with 2-methoxyestradiol (2ME2) [PubChem=1573].	23	9.450565e-3	1.000000e+0	1.000000e+0	1.058138e+2	9.450565e-3	1	9.450565e-3	1.000000e+0	25	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	HLA-E
MSigDB Perturbation	STEIN_ESRRA_TARGETS_DN	Genes down-regulated by ESRRA [GeneID=2101] only.	24	9.539844e-3	1.000000e+0	1.000000e+0	1.048235e+2	9.539844e-3	1	9.539844e-3	1.000000e+0	23	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	HLA-E
MSigDB Perturbation	ZHU_CMV_ALL_UP	Up-regulated at any timepoint following infection of primary human foreskin fibroblasts with CMV	25	9.684409e-3	1.000000e+0	1.000000e+0	1.032588e+2	9.684409e-3	1	9.684409e-3	1.000000e+0	24	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	HLA-E
MSigDB Perturbation	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	Top 100 genes positively associated with T-cell acute lymphoblastic leukemia MLL T-ALL) expressing MLL-ENL fusion [GeneID=4297;4298].	26	9.779345e-3	1.000000e+0	1.000000e+0	1.022563e+2	9.779345e-3	1	9.779345e-3	1.000000e+0	19	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	HLA-E
MSigDB Perturbation	BASSO_B_LYMPHOCYTE_NETWORK	Genes which comprise the top 1% of highly interconnected genes (major hubs) that account for most of gene interactions in the reconstructed regulatory networks from expression profiles in B lymphocytes.	27	1.057384e-2	1.000000e+0	1.000000e+0	9.457301e+1	1.057384e-2	1	1.057384e-2	1.000000e+0	27	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	HLA-E
MSigDB Perturbation	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	Genes up-regulated in RD-EF cells (rhabdomyosarcoma) engineered to express EWSR1-FLI1 fusion [GeneID=2130;2313] and which are also highly expressed in Ewing's famliy tumors.	28	1.132261e-2	1.000000e+0	1.000000e+0	8.831887e+1	1.132261e-2	1	1.132261e-2	1.000000e+0	18	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	HLA-E
MSigDB Perturbation	HUANG_GATA2_TARGETS_UP	Genes up-regulated in G1ME cells (megakaryocyte/erythroid progenitor lacking GATA1 [GeneID=2623]) upon knockdown of GATA2 [GeneID=2624] by RNAi.	29	1.315558e-2	1.000000e+0	1.000000e+0	7.601339e+1	1.315558e-2	1	1.315558e-2	1.000000e+0	28	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	HLA-E
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	Genes up-regulated in fibroblasts expressing mutant forms of ERCC3 [GeneID=2071] after UV irradiation.	30	1.435576e-2	1.000000e+0	1.000000e+0	6.965846e+1	1.435576e-2	1	1.435576e-2	1.000000e+0	40	3.341799e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	304	5.000000e-1	3.289474e-3	unnamed	HLA-E
MSigDB Perturbation	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	Genes down-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	31	1.621223e-2	1.000000e+0	1.000000e+0	6.168181e+1	1.621223e-2	1	1.621223e-2	1.000000e+0	29	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	HLA-E
MSigDB Perturbation	BAKKER_FOXO3_TARGETS_DN	Genes down-regulated in I/11 erythroblast cells upon expression of an activated form of FOXO3 [GeneID=2309].	32	1.682645e-2	1.000000e+0	1.000000e+0	5.943023e+1	1.682645e-2	1	1.682645e-2	1.000000e+0	31	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	RPP21
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) upon serum deprivation for 22 hr in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	33	2.147510e-2	1.000000e+0	1.000000e+0	4.656556e+1	2.147510e-2	1	2.147510e-2	1.000000e+0	34	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	HLA-E
MSigDB Perturbation	HSIAO_HOUSEKEEPING_GENES	Housekeeping genes identified as expressed across 19 normal tissues.	34	2.209482e-2	1.000000e+0	1.000000e+0	4.525947e+1	2.209482e-2	1	2.209482e-2	1.000000e+0	46	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	HLA-E
MSigDB Perturbation	HOLLMANN_APOPTOSIS_VIA_CD40_DN	Genes down-regulated in DLBCL (diffuse large B-cell lymphoma) cell lines sensitive to stimulation of CD40 [GeneID=958] relative to the resistant ones.	35	2.285226e-2	1.000000e+0	1.000000e+0	4.375935e+1	2.285226e-2	1	2.285226e-2	1.000000e+0	37	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	HLA-E
MSigDB Perturbation	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	Up-regulated genes from the set A (Fig. 5a): specific to cells expressing MLL-AF4 [GeneID=4297;4299] fusion protein alone.	36	2.483739e-2	1.000000e+0	1.000000e+0	4.026189e+1	2.483739e-2	1	2.483739e-2	1.000000e+0	31	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	HLA-E
MSigDB Perturbation	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	Genes indentified by RNAi screen as regulating infection of THP-1 cells (macrophage) with Mycobacterium tuberculosis.	37	2.567805e-2	1.000000e+0	1.000000e+0	3.894377e+1	2.567805e-2	1	2.567805e-2	1.000000e+0	38	2.817922e-2	1.000000e+0	1.000000e+0	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	HLA-E
MSigDB Perturbation	RUTELLA_RESPONSE_TO_HGF_DN	Genes down-regulated in peripheral blood monocytes by HGF [GeneID=3082].	38	2.776576e-2	1.000000e+0	1.000000e+0	3.601558e+1	2.776576e-2	1	2.776576e-2	1.000000e+0	35	2.511674e-2	1.000000e+0	1.000000e+0	3.956360e+1	2.527576e-2	1	228	5.000000e-1	4.385965e-3	unnamed	HLA-E
MSigDB Perturbation	WALLACE_PROSTATE_CANCER_RACE_UP	Genes up-regulated in prostate cancer samples from African-American patients compared to those from the European-American patients.	39	2.937598e-2	1.000000e+0	1.000000e+0	3.404142e+1	2.937598e-2	1	2.937598e-2	1.000000e+0	39	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	HLA-E
MSigDB Perturbation	MANALO_HYPOXIA_UP	Genes up-regulated in response to both hypoxia and overexpression of an active form of HIF1A [GeneID=3091].	40	2.970945e-2	1.000000e+0	1.000000e+0	3.365933e+1	2.970945e-2	1	2.970945e-2	1.000000e+0	33	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	HLA-E
MSigDB Perturbation	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	Genes commonly up-regulated in UET-13 cells (mesenchymal progenitor) by expression of EWSR1 [GeneID=2130] fusions with ETS transcription factors FLI1 and ERG [GeneID=2313 ,2078].	41	3.180163e-2	1.000000e+0	1.000000e+0	3.144493e+1	3.180163e-2	1	3.180163e-2	1.000000e+0	36	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	HLA-E
MSigDB Perturbation	ENK_UV_RESPONSE_KERATINOCYTE_UP	Genes up-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.	42	3.205700e-2	1.000000e+0	1.000000e+0	3.119443e+1	3.205700e-2	1	3.205700e-2	1.000000e+0	57	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	HLA-E
MSigDB Perturbation	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	Genes down-regulated in peripheral blood monocytes by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].	43	3.293263e-2	1.000000e+0	1.000000e+0	3.036502e+1	3.293263e-2	1	3.293263e-2	1.000000e+0	41	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	HLA-E
MSigDB Perturbation	BRUINS_UVC_RESPONSE_EARLY_LATE	Early-late response genes: differentially expressed in the first 3 h and after 12 h following UV-C irradiation of MEF cells (embryonic fibroblast).	44	3.354868e-2	1.000000e+0	1.000000e+0	2.980743e+1	3.354868e-2	1	3.354868e-2	1.000000e+0	41	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	RPP21
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_UP	Genes up-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	45	3.673544e-2	1.000000e+0	1.000000e+0	2.722167e+1	3.673544e-2	1	3.673544e-2	1.000000e+0	48	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	HLA-E
MSigDB Perturbation	GARY_CD5_TARGETS_UP	Genes up-regulated in Daudi cells (B lymphocytes) stably expressing CD5 [GeneID=921] off a plasmid vector.	46	3.747592e-2	1.000000e+0	1.000000e+0	2.668380e+1	3.747592e-2	1	3.747592e-2	1.000000e+0	54	5.034621e-2	1.000000e+0	1.000000e+0	1.960978e+1	5.099496e-2	1	460	5.000000e-1	2.173913e-3	unnamed	HLA-E
MSigDB Perturbation	RODWELL_AGING_KIDNEY_UP	Genes whose expression increases with age in normal kidney.	47	4.139156e-2	1.000000e+0	1.000000e+0	2.415951e+1	4.139156e-2	1	4.139156e-2	1.000000e+0	52	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	HLA-E
MSigDB Perturbation	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	Genes up-regulated in peripheral blood mononucleocytes by HGF [GeneID=3082] compared to those regulated by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].	48	4.168157e-2	1.000000e+0	1.000000e+0	2.399142e+1	4.168157e-2	1	4.168157e-2	1.000000e+0	47	4.374465e-2	1.000000e+0	1.000000e+0	2.260777e+1	4.423258e-2	1	399	5.000000e-1	2.506266e-3	unnamed	HLA-E
MSigDB Perturbation	MITSIADES_RESPONSE_TO_APLIDIN_UP	Genes up-regulated in the MM1S cells (multiple myeloma) after treatment with aplidin [PubChem=44152164], a marine-derived compound with potential anti-cancer properties.	49	4.213585e-2	1.000000e+0	1.000000e+0	2.373276e+1	4.213585e-2	1	4.213585e-2	1.000000e+0	51	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	HLA-E
MSigDB Perturbation	BASAKI_YBX1_TARGETS_DN	Genes down-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	50	4.411758e-2	1.000000e+0	1.000000e+0	2.266670e+1	4.411758e-2	1	4.411758e-2	1.000000e+0	44	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	HLA-E
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	Genes down-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	51	4.483636e-2	1.000000e+0	1.000000e+0	2.230333e+1	4.483636e-2	1	4.483636e-2	1.000000e+0	43	3.537888e-2	1.000000e+0	1.000000e+0	2.801398e+1	3.569647e-2	1	322	5.000000e-1	3.105590e-3	unnamed	HLA-E
MSigDB Perturbation	STEIN_ESRRA_TARGETS	Genes regulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	52	4.591289e-2	1.000000e+0	1.000000e+0	2.178037e+1	4.591289e-2	1	4.591289e-2	1.000000e+0	55	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	HLA-E
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_2B	Genes specifically up-regulated in Cluster IIb of urothelial cell carcinom (UCC) tumors.	53	4.661543e-2	1.000000e+0	1.000000e+0	2.145212e+1	4.661543e-2	1	4.661543e-2	1.000000e+0	45	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	HLA-E
MSigDB Perturbation	FEVR_CTNNB1_TARGETS_UP	Genes up-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	54	5.094385e-2	1.000000e+0	1.000000e+0	1.962946e+1	5.094385e-2	1	5.094385e-2	1.000000e+0	59	7.257778e-2	1.000000e+0	1.000000e+0	1.352399e+1	7.394269e-2	1	667	5.000000e-1	1.499250e-3	unnamed	HLA-E
MSigDB Perturbation	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	Genes down-regulated in luminal-like breast cancer cell lines compared to the basal-like ones.	55	5.472836e-2	1.000000e+0	1.000000e+0	1.827206e+1	5.472836e-2	1	5.472836e-2	1.000000e+0	50	4.785978e-2	1.000000e+0	1.000000e+0	2.064188e+1	4.844521e-2	1	437	5.000000e-1	2.288330e-3	unnamed	HLA-E
MSigDB Perturbation	GRADE_COLON_CANCER_UP	Up-regulated genes in colon carcinoma tumors compared to the matched normal mucosa samples.	56	5.482550e-2	1.000000e+0	1.000000e+0	1.823969e+1	5.482550e-2	1	5.482550e-2	1.000000e+0	64	9.306856e-2	1.000000e+0	1.000000e+0	1.048895e+1	9.533840e-2	1	860	5.000000e-1	1.162791e-3	unnamed	RPP21
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis upon serum starvation (5% to 0% FCS) for 22 hr.	57	5.536438e-2	1.000000e+0	1.000000e+0	1.806215e+1	5.536438e-2	1	5.536438e-2	1.000000e+0	56	5.886179e-2	1.000000e+0	1.000000e+0	1.673562e+1	5.975279e-2	1	539	5.000000e-1	1.855288e-3	unnamed	HLA-E
MSigDB Perturbation	LIU_PROSTATE_CANCER_DN	Genes down-regulated in prostate cancer samples.	58	5.894800e-2	1.000000e+0	1.000000e+0	1.696410e+1	5.894800e-2	1	5.894800e-2	1.000000e+0	53	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	HLA-E
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	Genes up-regulated in liver tumor compared to the normal adjacent tissue.	59	6.025185e-2	1.000000e+0	1.000000e+0	1.659700e+1	6.025185e-2	1	6.025185e-2	1.000000e+0	63	9.169554e-2	1.000000e+0	1.000000e+0	1.064994e+1	9.389723e-2	1	847	5.000000e-1	1.180638e-3	unnamed	RPP21
MSigDB Perturbation	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	Down-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone.	60	6.253641e-2	1.000000e+0	1.000000e+0	1.599068e+1	6.253641e-2	1	6.253641e-2	1.000000e+0	58	6.508932e-2	1.000000e+0	1.000000e+0	1.510972e+1	6.618258e-2	1	597	5.000000e-1	1.675042e-3	unnamed	HLA-E
MSigDB Perturbation	LOPEZ_MBD_TARGETS	Genes up-regulated in HeLa cells (cervical cancer) after simultaneus knockdown of all three MBD (methyl-CpG binding domain) proteins MeCP2, MBD1 and MBD2 [GeneID=4204;4152;8932] by RNAi.	61	6.397820e-2	1.000000e+0	1.000000e+0	1.563032e+1	6.397820e-2	1	6.397820e-2	1.000000e+0	66	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	HLA-E
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	62	6.489857e-2	1.000000e+0	1.000000e+0	1.540866e+1	6.489857e-2	1	6.489857e-2	1.000000e+0	61	8.099287e-2	1.000000e+0	1.000000e+0	1.209182e+1	8.270052e-2	1	746	5.000000e-1	1.340483e-3	unnamed	RPP21
MSigDB Perturbation	RIGGI_EWING_SARCOMA_PROGENITOR_UP	Genes up-regulated in mesenchymal stem cells (MSC) engineered to express EWS-FLI1 [GeneID=2130;2321] fusion protein.	63	7.155100e-2	1.000000e+0	1.000000e+0	1.397605e+1	7.155100e-2	1	7.155100e-2	1.000000e+0	49	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	HLA-E
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	Genes up-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	64	7.473849e-2	1.000000e+0	1.000000e+0	1.337999e+1	7.473849e-2	1	7.473849e-2	1.000000e+0	60	7.631072e-2	1.000000e+0	1.000000e+0	1.284972e+1	7.782274e-2	1	702	5.000000e-1	1.424501e-3	unnamed	HLA-E
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_UP	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	65	7.903216e-2	1.000000e+0	1.000000e+0	1.265308e+1	7.903216e-2	1	7.903216e-2	1.000000e+0	67	1.017052e-1	1.000000e+0	1.000000e+0	9.575902e+0	1.044288e-1	1	942	5.000000e-1	1.061571e-3	unnamed	HLA-E
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_UP	Genes up-regulated in uveal melanoma: class 2 vs class 1 tumors.	66	8.290379e-2	1.000000e+0	1.000000e+0	1.206218e+1	8.290379e-2	1	8.290379e-2	1.000000e+0	62	8.311719e-2	1.000000e+0	1.000000e+0	1.177611e+1	8.491769e-2	1	766	5.000000e-1	1.305483e-3	unnamed	HLA-E
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	Genes up-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	67	9.102346e-2	1.000000e+0	1.000000e+0	1.098618e+1	9.102346e-2	1	9.102346e-2	1.000000e+0	65	9.338526e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	863	5.000000e-1	1.158749e-3	unnamed	HLA-E
MSigDB Perturbation	NUYTTEN_EZH2_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	68	1.213858e-1	1.000000e+0	1.000000e+0	8.238198e+0	1.213858e-1	1	1.213858e-1	1.000000e+0	68	1.078938e-1	1.000000e+0	1.000000e+0	9.011489e+0	1.109695e-1	1	1001	5.000000e-1	9.990010e-4	unnamed	HLA-E
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_UP	Genes up-regulated in brain from patients with Alzheimer's disease.	69	1.561268e-1	1.000000e+0	1.000000e+0	6.405052e+0	1.561268e-1	1	1.561268e-1	1.000000e+0	69	1.768717e-1	1.000000e+0	1.000000e+0	5.391811e+0	1.854664e-1	1	1673	5.000000e-1	5.977286e-4	unnamed	HLA-E
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	70	1.826173e-1	1.000000e+0	1.000000e+0	5.475932e+0	1.826173e-1	1	1.826173e-1	1.000000e+0	70	1.827952e-1	1.000000e+0	1.000000e+0	5.208141e+0	1.920071e-1	1	1732	5.000000e-1	5.773672e-4	unnamed	RPP21
MSigDB Predicted Promoter Motifs	GCCNNNWTAAR_UNKNOWN	Motif GCCNNNWTAAR (no known TF)	1	2.147566e-2	1.000000e+0	1.000000e+0	4.656434e+1	2.147566e-2	1	2.147566e-2	1.000000e+0	1	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	RTTTNNNYTGGM_UNKNOWN	Motif RTTTNNNYTGGM (no known TF)	2	2.626066e-2	1.000000e+0	1.000000e+0	3.807978e+1	2.626066e-2	1	2.626066e-2	1.000000e+0	2	1.656012e-2	1.000000e+0	1.000000e+0	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$NCX_01	Motif NNGTAAKTNG matches TLX2: T-cell leukemia homeobox 2	3	2.767319e-2	1.000000e+0	1.000000e+0	3.613606e+1	2.767319e-2	1	2.767319e-2	1.000000e+0	3	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	RACCACAR_V$AML_Q6	Motif RACCACAR matches RUNX1: runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)	4	2.866166e-2	1.000000e+0	1.000000e+0	3.488982e+1	2.866166e-2	1	2.866166e-2	1.000000e+0	8	2.774202e-2	1.000000e+0	1.000000e+0	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$SMAD_Q6	Motif AGACNBCNN matches SMAD1: SMAD, mothers against DPP homolog 1 (Drosophila)	5	2.944269e-2	1.000000e+0	1.000000e+0	3.396429e+1	2.944269e-2	1	2.944269e-2	1.000000e+0	5	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$EFC_Q6	Motif MGTTACYAGGCAAM matches RFX1: regulatory factor X, 1 (influences HLA class II expression)	6	2.959531e-2	1.000000e+0	1.000000e+0	3.378914e+1	2.959531e-2	1	2.959531e-2	1.000000e+0	6	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	ACTAYRNNNCCCR_UNKNOWN	Motif ACTAYRNNNCCCR (no known TF)	7	3.045559e-2	1.000000e+0	1.000000e+0	3.283469e+1	3.045559e-2	1	3.045559e-2	1.000000e+0	14	4.634471e-2	1.000000e+0	1.000000e+0	2.132506e+1	4.689319e-2	1	423	5.000000e-1	2.364066e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$OSF2_Q6	Motif ACCACANM matches RUNX2: runt-related transcription factor 2	8	3.144969e-2	1.000000e+0	1.000000e+0	3.179682e+1	3.144969e-2	1	3.144969e-2	1.000000e+0	10	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$LEF1_Q6	Motif SWWCAAAGGG matches LEF1: lymphoid enhancer-binding factor 1&lt;br&gt; TCF1: transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor	9	3.520976e-2	1.000000e+0	1.000000e+0	2.840122e+1	3.520976e-2	1	3.520976e-2	1.000000e+0	6	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$HNF4ALPHA_Q6	Motif VTGAACTTTGMMB matches HNF4A: hepatocyte nuclear factor 4, alpha	10	3.526112e-2	1.000000e+0	1.000000e+0	2.835985e+1	3.526112e-2	1	3.526112e-2	1.000000e+0	8	2.774202e-2	1.000000e+0	1.000000e+0	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$OCT_Q6	Motif TNATTTGCATN (no known TF)	11	3.698297e-2	1.000000e+0	1.000000e+0	2.703947e+1	3.698297e-2	1	3.698297e-2	1.000000e+0	11	2.938103e-2	1.000000e+0	1.000000e+0	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$OCT1_05	Motif MKVATTTGCATATT matches POU2F1: POU domain, class 2, transcription factor 1	12	4.002346e-2	1.000000e+0	1.000000e+0	2.498535e+1	4.002346e-2	1	4.002346e-2	1.000000e+0	4	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$OCT1_Q5_01	Motif TNATTTGCATW matches POU2F1: POU domain, class 2, transcription factor 1	13	4.021280e-2	1.000000e+0	1.000000e+0	2.486770e+1	4.021280e-2	1	4.021280e-2	1.000000e+0	13	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	V$OCT1_Q6	Motif NNNNATGCAAATNAN matches POU2F1: POU domain, class 2, transcription factor 1	14	4.317370e-2	1.000000e+0	1.000000e+0	2.316225e+1	4.317370e-2	1	4.317370e-2	1.000000e+0	12	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	TGCCAAR_V$NF1_Q6	Motif TGCCAAR matches NF1: neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	15	9.403888e-2	1.000000e+0	1.000000e+0	1.063390e+1	9.403888e-2	1	9.403888e-2	1.000000e+0	16	7.417853e-2	1.000000e+0	1.000000e+0	1.322654e+1	7.560557e-2	1	682	5.000000e-1	1.466276e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	YTATTTTNR_V$MEF2_02	Motif YTATTTTNR matches MEF2A: MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	16	1.016792e-1	1.000000e+0	1.000000e+0	9.834855e+0	1.016792e-1	1	1.016792e-1	1.000000e+0	15	7.268454e-2	1.000000e+0	1.000000e+0	1.350374e+1	7.405354e-2	1	668	5.000000e-1	1.497006e-3	unnamed	RPP21
MSigDB Predicted Promoter Motifs	CTTTGT_V$LEF1_Q2	Motif CTTTGT matches LEF1: lymphoid enhancer-binding factor 1	17	2.442153e-1	1.000000e+0	1.000000e+0	4.094747e+0	2.442153e-1	1	2.442153e-1	1.000000e+0	17	1.979574e-1	1.000000e+0	1.000000e+0	4.787951e+0	2.088576e-1	1	1884	5.000000e-1	5.307856e-4	unnamed	RPP21
InterPro	IPR007175	RNAse P, Rpr2/Rpp21 subunit	1	5.587749e-5	5.264777e-1	5.264777e-1	1.789630e+4	5.587749e-5	1	5.587749e-5	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	RPP21
InterPro	IPR010579	MHC class I, alpha chain, C-terminal	2	2.295823e-4	1.000000e+0	1.000000e+0	4.355737e+3	2.295823e-4	1	2.295823e-4	1.000000e+0	2	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	HLA-E
InterPro	IPR027648	MHC class I alpha chain	3	4.777243e-4	1.000000e+0	1.000000e+0	2.093258e+3	4.777243e-4	1	4.777243e-4	1.000000e+0	3	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	HLA-E
InterPro	IPR001039	MHC class I alpha chain, alpha1 alpha2 domains	4	6.753762e-4	1.000000e+0	1.000000e+0	1.480656e+3	6.753762e-4	1	6.753762e-4	1.000000e+0	4	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	HLA-E
InterPro	IPR011161	MHC class I-like antigen recognition	5	7.896670e-4	1.000000e+0	1.000000e+0	1.266357e+3	7.896670e-4	1	7.896670e-4	1.000000e+0	5	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	HLA-E
InterPro	IPR011162	MHC classes I/II-like antigen recognition protein	6	1.054619e-3	1.000000e+0	1.000000e+0	9.482098e+2	1.054619e-3	1	1.054619e-3	1.000000e+0	7	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	HLA-E
InterPro	IPR003597	Immunoglobulin C1-set	7	1.580488e-3	1.000000e+0	1.000000e+0	6.327158e+2	1.580488e-3	1	1.580488e-3	1.000000e+0	8	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	HLA-E
InterPro	IPR003006	Immunoglobulin/major histocompatibility complex, conserved site	8	1.584030e-3	1.000000e+0	1.000000e+0	6.313013e+2	1.584030e-3	1	1.584030e-3	1.000000e+0	6	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	HLA-E
InterPro	IPR007110	Immunoglobulin-like domain	9	5.020399e-2	1.000000e+0	1.000000e+0	1.991873e+1	5.020399e-2	1	5.020399e-2	1.000000e+0	9	4.710240e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	430	5.000000e-1	2.325581e-3	unnamed	HLA-E
InterPro	IPR013783	Immunoglobulin-like fold	10	7.916806e-2	1.000000e+0	1.000000e+0	1.263136e+1	7.916806e-2	1	7.916806e-2	1.000000e+0	10	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	HLA-E
TreeFam	TF323865	RPP21, TRIM39-RPP21	1	5.587749e-5	4.540605e-1	4.540605e-1	1.789630e+4	5.587749e-5	1	5.587749e-5	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	RPP21
Ensembl Genes	16169	RPP21	1	5.378057e-5	9.702553e-1	9.702553e-1	1.859407e+4	5.378057e-5	1	5.378057e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	RPP21
Ensembl Genes	16170	HLA-E	2	7.190839e-5	1.000000e+0	6.486496e-1	1.390658e+4	7.190839e-5	1	7.190839e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	HLA-E
MSigDB Oncogenic Signatures	PKCA_DN.V1_UP	Genes up-regulated in small intenstine in PRKCA [Gene ID=5578] knockout mice.	1	1.118868e-2	1.000000e+0	1.000000e+0	8.937607e+1	1.118868e-2	1	1.118868e-2	1.000000e+0	1	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	HLA-E
MSigDB Oncogenic Signatures	RAPA_EARLY_UP.V1_DN	Genes down-regulated in BJAB (lymphoma) cells by everolimus [PubChem = 6442177].	2	1.585509e-2	1.000000e+0	1.000000e+0	6.307122e+1	1.585509e-2	1	1.585509e-2	1.000000e+0	3	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	HLA-E
MSigDB Oncogenic Signatures	E2F1_UP.V1_DN	Genes down-regulated in mouse fibroblasts over-expressing E2F1 [Gene ID=1869] gene.	3	2.216589e-2	1.000000e+0	1.000000e+0	4.511436e+1	2.216589e-2	1	2.216589e-2	1.000000e+0	2	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	1	1.079431e-2	1.000000e+0	1.000000e+0	9.264141e+1	1.079431e-2	1	1.079431e-2	1.000000e+0	15	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.	2	1.134990e-2	1.000000e+0	1.000000e+0	8.810647e+1	1.134990e-2	1	1.134990e-2	1.000000e+0	5	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. pneumoniae infection.	3	1.152625e-2	1.000000e+0	1.000000e+0	8.675848e+1	1.152625e-2	1	1.152625e-2	1.000000e+0	4	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 1 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	4	1.276108e-2	1.000000e+0	1.000000e+0	7.836330e+1	1.276108e-2	1	1.276108e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	Genes up-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	5	1.338771e-2	1.000000e+0	1.000000e+0	7.469535e+1	1.338771e-2	1	1.338771e-2	1.000000e+0	5	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP	Genes up-regulated in comparison of Jurkat T cells stimulated in the presence of PD-1 versus controls.	6	1.402972e-2	1.000000e+0	1.000000e+0	7.127728e+1	1.402972e-2	1	1.402972e-2	1.000000e+0	31	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE27786_LIN_NEG_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of lineage negative versus neutrophils.	7	1.436723e-2	1.000000e+0	1.000000e+0	6.960282e+1	1.436723e-2	1	1.436723e-2	1.000000e+0	27	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP	Genes up-regulated in comparison of unstimulated CD8 T cells at 48 h versus CD8 T cells at 48 h after stimulation with antigen-B7-1.	8	1.450646e-2	1.000000e+0	1.000000e+0	6.893482e+1	1.450646e-2	1	1.450646e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN	Genes down-regulated in comparison of untreated CD8+ dendritic cells (DC) at 4 h versus those treated with IFNG [GeneID=3458] at 16 h.	9	1.458652e-2	1.000000e+0	1.000000e+0	6.855644e+1	1.458652e-2	1	1.458652e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE360_CTRL_VS_L_MAJOR_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to L. major.	10	1.474389e-2	1.000000e+0	1.000000e+0	6.782470e+1	1.474389e-2	1	1.474389e-2	1.000000e+0	60	2.183015e-2	1.000000e+0	6.949264e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 0.5 h.	11	1.478674e-2	1.000000e+0	1.000000e+0	6.762815e+1	1.478674e-2	1	1.478674e-2	1.000000e+0	18	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_4H_VS_24H_POLYIC_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus those stimulated at 24 h.	12	1.490526e-2	1.000000e+0	1.000000e+0	6.709040e+1	1.490526e-2	1	1.490526e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	13	1.500117e-2	1.000000e+0	1.000000e+0	6.666145e+1	1.500117e-2	1	1.500117e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB3 [GeneID=7043] and IL6 [GeneID=3569] versus those treated with TGF3B [GeneID=7043], IL6 [GeneID=3569] and IL23A [GeneID=51561].	14	1.521143e-2	1.000000e+0	1.000000e+0	6.574003e+1	1.521143e-2	1	1.521143e-2	1.000000e+0	12	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	Genes down-regulated in comparison of memory CD8 T cells versus those  treated with IL4 [GeneID=3565] and IL7 [GeneID=3574].	15	1.521611e-2	1.000000e+0	1.000000e+0	6.571983e+1	1.521611e-2	1	1.521611e-2	1.000000e+0	55	2.172051e-2	1.000000e+0	7.542941e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 4 h.	16	1.523782e-2	1.000000e+0	1.000000e+0	6.562617e+1	1.523782e-2	1	1.523782e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	17	1.545615e-2	1.000000e+0	1.000000e+0	6.469917e+1	1.545615e-2	1	1.545615e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_CD4_TCELL_DN	Genes down-regulated in comparison of B cells versus CD4 [GeneID=920] T cells.	18	1.557999e-2	1.000000e+0	1.000000e+0	6.418490e+1	1.557999e-2	1	1.557999e-2	1.000000e+0	8	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.	19	1.581932e-2	1.000000e+0	1.000000e+0	6.321385e+1	1.581932e-2	1	1.581932e-2	1.000000e+0	73	2.204943e-2	1.000000e+0	5.769097e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP	Genes up-regulated in comparison of macrophage cells stimulated with LPS (TLR4 agonist) for 40 min versus macrophage cells stimulated with LPS (TLR4 agonist) for 360 min.	20	1.583242e-2	1.000000e+0	1.000000e+0	6.316153e+1	1.583242e-2	1	1.583242e-2	1.000000e+0	55	2.172051e-2	1.000000e+0	7.542941e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE22886_CTRL_VS_LPS_24H_DC_DN	Genes down-regulated in comparison of unstimulated dendritic cells (DC) versus 1 day DC stimulated with LPS (TLR4 agonist).	21	1.585042e-2	1.000000e+0	1.000000e+0	6.308980e+1	1.585042e-2	1	1.585042e-2	1.000000e+0	77	2.336458e-2	1.000000e+0	5.795630e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP	Genes up-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.	22	1.604898e-2	1.000000e+0	1.000000e+0	6.230927e+1	1.604898e-2	1	1.604898e-2	1.000000e+0	11	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_PAM3CSK4_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h versus those stimulated at 8 h.	23	1.607105e-2	1.000000e+0	1.000000e+0	6.222369e+1	1.607105e-2	1	1.607105e-2	1.000000e+0	55	2.172051e-2	1.000000e+0	7.542941e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	24	1.607561e-2	1.000000e+0	1.000000e+0	6.220605e+1	1.607561e-2	1	1.607561e-2	1.000000e+0	55	2.172051e-2	1.000000e+0	7.542941e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	25	1.624824e-2	1.000000e+0	1.000000e+0	6.154512e+1	1.624824e-2	1	1.624824e-2	1.000000e+0	27	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_4H_PAM3CSK4_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h versus those stimulated at 4 h.	26	1.624962e-2	1.000000e+0	1.000000e+0	6.153991e+1	1.624962e-2	1	1.624962e-2	1.000000e+0	3	1.186384e-4	2.265993e-1	7.553311e-2	9.157868e+1	2.183914e-2	2	197	1.000000e+0	1.015228e-2	unnamed	HLA-E,RPP21
MSigDB Immunologic Signatures	GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN	Genes down-regulated in comparison of CD25+ T cells treated with IL4 [GeneID=3565] versus CD25- T cells treated with IL4 [GeneID=3565] at day 5.	27	1.626618e-2	1.000000e+0	1.000000e+0	6.147724e+1	1.626618e-2	1	1.626618e-2	1.000000e+0	12	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of naive CD8 T cells versus effector CD8 T cells KLRG1 high [GeneID=10219].	28	1.641226e-2	1.000000e+0	1.000000e+0	6.093004e+1	1.641226e-2	1	1.641226e-2	1.000000e+0	18	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of wild type CD8 effector T cells at day 6 versus those at day 10.	29	1.643549e-2	1.000000e+0	1.000000e+0	6.084394e+1	1.643549e-2	1	1.643549e-2	1.000000e+0	7	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].	30	1.663662e-2	1.000000e+0	1.000000e+0	6.010836e+1	1.663662e-2	1	1.663662e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_MONO_MAC_UP	Genes up-regulated in comparison of NK cells versus monocyte macrophages.	31	1.665736e-2	1.000000e+0	1.000000e+0	6.003353e+1	1.665736e-2	1	1.665736e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	32	1.666999e-2	1.000000e+0	9.949900e-1	5.998802e+1	1.666999e-2	1	1.666999e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE14308_TH1_VS_NATURAL_TREG_DN	Genes down-regulated in comparison of Th1 cells versus natural regulatory T cell (Treg).	33	1.678434e-2	1.000000e+0	9.714573e-1	5.957934e+1	1.678434e-2	1	1.678434e-2	1.000000e+0	15	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE10325_BCELL_VS_LUPUS_BCELL_DN	Genes down-regulated in comparison of healthy B cells versus systemic lupus erythematosus B cells.	34	1.703490e-2	1.000000e+0	9.569606e-1	5.870300e+1	1.703490e-2	1	1.703490e-2	1.000000e+0	55	2.172051e-2	1.000000e+0	7.542941e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	35	1.708449e-2	1.000000e+0	9.323250e-1	5.853262e+1	1.708449e-2	1	1.708449e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_0.5H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	36	1.713390e-2	1.000000e+0	9.090486e-1	5.836384e+1	1.713390e-2	1	1.713390e-2	1.000000e+0	1	1.091748e-4	2.085239e-1	2.085239e-1	9.545503e+1	2.095228e-2	2	189	1.000000e+0	1.058201e-2	unnamed	HLA-E,RPP21
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	37	1.714721e-2	1.000000e+0	8.851668e-1	5.831854e+1	1.714721e-2	1	1.714721e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN	Genes down-regulated in comparison of memory CD8 T cells versus those  treated with IL4 [GeneID=3565].	38	1.723003e-2	1.000000e+0	8.660357e-1	5.803820e+1	1.723003e-2	1	1.723003e-2	1.000000e+0	18	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC stimulated with YF17D vaccine.	39	1.730318e-2	1.000000e+0	8.474121e-1	5.779284e+1	1.730318e-2	1	1.730318e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE360_CTRL_VS_L_DONOVANI_DC_UP	Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite L. donovani.	40	1.732012e-2	1.000000e+0	8.270357e-1	5.773631e+1	1.732012e-2	1	1.732012e-2	1.000000e+0	31	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 6 h after the stimulation.	41	1.744963e-2	1.000000e+0	8.128974e-1	5.730780e+1	1.744963e-2	1	1.744963e-2	1.000000e+0	60	2.183015e-2	1.000000e+0	6.949264e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	Genes down-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].	42	1.749438e-2	1.000000e+0	7.955778e-1	5.716122e+1	1.749438e-2	1	1.749438e-2	1.000000e+0	73	2.204943e-2	1.000000e+0	5.769097e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 4 h.	43	1.751991e-2	1.000000e+0	7.782100e-1	5.707791e+1	1.751991e-2	1	1.751991e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).	44	1.761152e-2	1.000000e+0	7.645001e-1	5.678101e+1	1.761152e-2	1	1.761152e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 0.5 h.	45	1.766087e-2	1.000000e+0	7.496058e-1	5.662236e+1	1.766087e-2	1	1.766087e-2	1.000000e+0	27	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	Genes down-regulated in comparison of unstimulated CD8 T cells at 48 h versus CD8 T cells at 48 h after treatment with trichostatin A (TSA) [PubChem=5562].	46	1.771868e-2	1.000000e+0	7.357104e-1	5.643761e+1	1.771868e-2	1	1.771868e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_PAM3CSK4_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h versus those stimulated at 24 h.	47	1.775469e-2	1.000000e+0	7.215204e-1	5.632316e+1	1.775469e-2	1	1.775469e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h.	48	1.792046e-2	1.000000e+0	7.130850e-1	5.580213e+1	1.792046e-2	1	1.792046e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	49	1.795105e-2	1.000000e+0	6.997246e-1	5.570706e+1	1.795105e-2	1	1.795105e-2	1.000000e+0	31	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	50	1.795528e-2	1.000000e+0	6.858917e-1	5.569392e+1	1.795528e-2	1	1.795528e-2	1.000000e+0	2	1.150435e-4	2.197331e-1	1.098665e-1	9.299485e+1	2.150657e-2	2	194	1.000000e+0	1.030928e-2	unnamed	HLA-E,RPP21
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP	Genes up-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 48 h.	51	1.797069e-2	1.000000e+0	6.730200e-1	5.564618e+1	1.797069e-2	1	1.797069e-2	1.000000e+0	12	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP	Genes up-regulated in comparison of virus specific (gp33) exhausted CD8 T cells versus the virus specific (gp276) cells.	52	1.799985e-2	1.000000e+0	6.611483e-1	5.555601e+1	1.799985e-2	1	1.799985e-2	1.000000e+0	60	2.183015e-2	1.000000e+0	6.949264e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	53	1.818883e-2	1.000000e+0	6.554843e-1	5.497881e+1	1.818883e-2	1	1.818883e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE2826_WT_VS_BTK_KO_BCELL_UP	Genes up-regulated in comparison of primary splenic B cells from wild type mice versus those from BTK [GeneID=695] knockout mice.	54	1.832401e-2	1.000000e+0	6.481270e-1	5.457322e+1	1.832401e-2	1	1.832401e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_CPG_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 8 h.	55	1.887685e-2	1.000000e+0	6.555415e-1	5.297494e+1	1.887685e-2	1	1.887685e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP	Genes up-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from TLR4 [GeneID=7099] deficient mice subjected to ozone for 48 h.	56	1.891428e-2	1.000000e+0	6.451120e-1	5.287011e+1	1.891428e-2	1	1.891428e-2	1.000000e+0	31	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP	Genes up-regulated in comparison of memory CD8 T cells versus naive CD8 T cells.	57	1.892450e-2	1.000000e+0	6.341368e-1	5.284156e+1	1.892450e-2	1	1.892450e-2	1.000000e+0	15	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 24 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 24 h.	58	1.901723e-2	1.000000e+0	6.262571e-1	5.258390e+1	1.901723e-2	1	1.901723e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 8 h.	59	1.904330e-2	1.000000e+0	6.164865e-1	5.251191e+1	1.904330e-2	1	1.904330e-2	1.000000e+0	60	2.183015e-2	1.000000e+0	6.949264e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes stimulated with anti-Valpha2 antibodies versus CD4 [GeneID=920] CD8 thymocytes stimulated with anti-beta5 antibodies.	60	1.907159e-2	1.000000e+0	6.071123e-1	5.243402e+1	1.907159e-2	1	1.907159e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.	61	1.922151e-2	1.000000e+0	6.018538e-1	5.202504e+1	1.922151e-2	1	1.922151e-2	1.000000e+0	10	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_CPG_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	62	1.937638e-2	1.000000e+0	5.969175e-1	5.160922e+1	1.937638e-2	1	1.937638e-2	1.000000e+0	73	2.204943e-2	1.000000e+0	5.769097e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 50 worm/well B. malayi.	63	1.938101e-2	1.000000e+0	5.875830e-1	5.159690e+1	1.938101e-2	1	1.938101e-2	1.000000e+0	31	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP	Genes up-regulated in comparison of adult thymic progenitors versus adult DN3 thymocytes.	64	1.942686e-2	1.000000e+0	5.797704e-1	5.147514e+1	1.942686e-2	1	1.942686e-2	1.000000e+0	18	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	65	1.980860e-2	1.000000e+0	5.820681e-1	5.048313e+1	1.980860e-2	1	1.980860e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 4 h.	66	1.982967e-2	1.000000e+0	5.738586e-1	5.042947e+1	1.982967e-2	1	1.982967e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 50 worms/well B. malayi.	67	1.995214e-2	1.000000e+0	5.687849e-1	5.011993e+1	1.995214e-2	1	1.995214e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE7852_LN_VS_THYMUS_TCONV_UP	Genes up-regulated in comparison of lymph node conventional T cells versus thymus conventional T cells.	68	2.010668e-2	1.000000e+0	5.647612e-1	4.973472e+1	2.010668e-2	1	2.010668e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP	Genes up-regulated in comparison of control CD4 [GeneID=920] CD8 thymocytes versus those after stimulation with anti-Vbeta5 antibodies.	69	2.070409e-2	1.000000e+0	5.731132e-1	4.829965e+1	2.070409e-2	1	2.070409e-2	1.000000e+0	27	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus DCs exposed to 5 worms/well B. malayi.	70	2.079762e-2	1.000000e+0	5.674779e-1	4.808243e+1	2.079762e-2	1	2.079762e-2	1.000000e+0	47	2.161085e-2	1.000000e+0	8.782282e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_T_GONDII_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus macrophages exposed to T. gondii.	71	2.092020e-2	1.000000e+0	5.627828e-1	4.780069e+1	2.092020e-2	1	2.092020e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP	Genes up-regulated in comparison of unstimulated CD8 T cells at 48 h versus CD8 T cells at 48 h after treatment with trichostatin A (TSA) [PubChem=5562].	72	2.126366e-2	1.000000e+0	5.640776e-1	4.702859e+1	2.126366e-2	1	2.126366e-2	1.000000e+0	64	2.193980e-2	1.000000e+0	6.547659e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	RPP21
MSigDB Immunologic Signatures	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	Genes up-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.	73	2.135447e-2	1.000000e+0	5.587265e-1	4.682861e+1	2.135447e-2	1	2.135447e-2	1.000000e+0	18	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 6 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 6 h.	74	2.170886e-2	1.000000e+0	5.603233e-1	4.606414e+1	2.170886e-2	1	2.170886e-2	1.000000e+0	18	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE1460_DP_VS_CD4_THYMOCYTE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.	75	2.223894e-2	1.000000e+0	5.663517e-1	4.496617e+1	2.223894e-2	1	2.223894e-2	1.000000e+0	31	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN	Genes down-regulated in comparison of splenic primary CD8 effector T cells at day 8 post-acute infection versus splenic secondary CD8 effector T cells at day 8 post-acute infection.	76	2.301245e-2	1.000000e+0	5.783392e-1	4.345474e+1	2.301245e-2	1	2.301245e-2	1.000000e+0	8	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	HLA-E
MSigDB Immunologic Signatures	GSE7852_LN_VS_THYMUS_TREG_UP	Genes up-regulated in comparison of lymph node regulatory T cells versus thymus regulatory T cells.	77	2.418923e-2	1.000000e+0	6.000186e-1	4.134071e+1	2.418923e-2	1	2.418923e-2	1.000000e+0	76	2.226868e-2	1.000000e+0	5.596471e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	HLA-E
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
